NeuroBo Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,.
NeuroBo Pharmaceuticals, Inc (NASDAQ:NRBO) Short Interest Update themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) – Equities researchers at Zacks Small Cap issued their Q1 2024 earnings estimates for NeuroBo Pharmaceuticals in a report issued on Tuesday, April 23rd. Zacks Small Cap analyst D. Bautz forecasts that the company will earn ($0.95) per share for the quarter. The consensus estimate for NeuroBo Pharmaceuticals’ […]
Ainos (NASDAQ:AIMD – Get Free Report) and NeuroBo Pharmaceuticals (NASDAQ:NRBO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Institutional and Insider Ownership 1.4% of NeuroBo Pharmaceuticals […]